(Reuters) -British stocks ended mixed on Friday, dragged down by the pharma sector and a stronger sterling hurting the export ...

Growth downgrades and the rise in bond yields in recent months have wiped out the £9.9 billion margin that Reeves left in her ...

Markets were reacting to president Donald Trump's move to impose 25% tariffs on steel and aluminium imports as well as ...

As the FTSE 100 trades near all-time highs in 2025, some of its top dividend shares still offer highly attractive yields for ...

GSK shares lead the FTSE 100 after it raised its growth guidance and announced a share buyback Join the Markets Today team -- ...

US economists are looking for monthly headline CPI at 0.31%, which would keep the year-on-year rate at 2.9%. Core CPI is ...

"Wide discounts, underperformance and, in some cases, board inaction have provoked the ire of activist investor Saba Capital ...

Strong results from AstraZeneca helped London's blue-chip index notch a record close on Thursday, while a dovish majority ...

This article looks at the FTSE 100 index and what to expect next week as several blue chip companies like Barclays and ...

Explore the factors behind the FTSE 100's record high, including corporate earnings, interest rate expectations, and sector ...

This is one of very few FTSE 100 stocks with a combination of a 9%+ yield, forecast earnings growth of 25%+, and a 50%+ share price undervaluation. When investing, your capital is at risk.